BioSpace News Archive

BioMidwest

Global Equipment Services, a Kimball Electronics Company, to Participate at the SPIE Photonics West Conference

Kimball Electronics, Inc. announced that its Global Equipment Services business will participate at the SPIE Photonics West Conference on Saturday, January 28, 2023 through Thursday, February 2, 2023 at The Moscone Center in San Francisco, CA.

January 26, 2023
·
2 min read
Genetown

Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI™).

January 26, 2023
·
9 min read
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease: BioArctic

BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI™).

January 26, 2023
·
6 min read
Rakovina Therapeutics Announces Presentation at the 6th Annual DDR-inhibitors Summit

Rakovina Therapeutics Inc., is pleased to announce a scientific presentation at the 6th Annual DDR Inhibitors Summit in Boston, MA.

January 26, 2023
·
4 min read